Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for treating fatty liver

A fatty liver and drug technology, applied in the direction of drug combination, pharmaceutical formula, active ingredients of hydroxyl compounds, etc., can solve the problem of not finding a completely satisfactory treatment plan, and achieve the effects of no toxic side effects, low price, and short course of treatment

Inactive Publication Date: 2017-05-31
郑州莉迪亚医药科技有限公司
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

So far, for the treatment of fatty liver, neither traditional Chinese medicine nor Western medicine has found a completely satisfactory treatment plan

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0016] A medicament for treating fatty liver, the main raw materials in parts by weight are: 8 parts of L-glutamine, 0.2 part of D-tryptophan, 4 parts of bocicol, 0.2 part of geraniol, glucuronolactone 10 parts, 3 parts of Corilagin, 0.9 parts of quercetin,

[0017] 0.2 parts of danshensu sodium, 4 parts of ethyl p-methoxycinnamate, and 1 part of silymarin.

[0018] A preparation method of a medicine for treating fatty liver, the specific steps are:

[0019] First, in a pharmaceutical-grade clean area, weigh L-glutamine, D-tryptophan, bucchiol, geraniol, glucuronolactone, corilagin, quercetin, Sodium danshensu, ethyl p-methoxycinnamate, silymarin, sieved, mechanically mixed, added ultrapure water, placed in a pharmaceutical mixer, mixed for 4 minutes, controlled RSD ≤ 5%, after mixing, pressed into tablets and dried at low temperature, The temperature is controlled at 10° C., and the medicine for treating fatty liver is obtained after packaging.

Embodiment 2

[0021] A medicament for treating fatty liver, the main raw materials in parts by weight are: 11 parts of L-glutamine, 0.4 parts of D-tryptophan, 5 parts of bocicol, 0.3 parts of geraniol, and glucuronolactone 12 parts, 4 parts of Corilagin, 1.2 parts of quercetin, 0.2 parts of danshensu sodium, 4 parts of ethyl p-methoxycinnamate, and 1 part of silymarin.

[0022] A preparation method of a medicine for treating fatty liver, the specific steps are:

[0023] First, in a pharmaceutical-grade clean area, weigh L-glutamine, D-tryptophan, bucchiol, geraniol, glucuronolactone, corilagin, quercetin, Sodium danshensu, ethyl p-methoxycinnamate, silymarin, sieved, mechanically mixed, added ultrapure water, placed in a pharmaceutical mixer, mixed for 4 minutes, controlled RSD ≤ 5%, after mixing, pressed into tablets and dried at low temperature, The temperature is controlled at 10° C., and the medicine for treating fatty liver is obtained after packaging.

Embodiment 3

[0025] A medicine for treating fatty liver, the main raw materials in parts by weight are: 14 parts of L-glutamine, 0.5 part of D-tryptophan, 6 parts of bocicol, 0.5 part of geraniol, and glucuronolactone 15 parts, 5 parts of corilagin, 1.3 parts of quercetin, 0.4 parts of danshensu sodium, 5 parts of ethyl p-methoxycinnamate, and 2 parts of silymarin.

[0026] A preparation method of a medicine for treating fatty liver, the specific steps are:

[0027] First, in a pharmaceutical-grade clean area, weigh L-glutamine, D-tryptophan, bucchiol, geraniol, glucuronolactone, corilagin, quercetin, Sodium danshensu, ethyl p-methoxycinnamate, silymarin, sieved, mechanically mixed, added ultrapure water, placed in a pharmaceutical mixer, mixed for 6 minutes, controlled RSD ≤ 5%, after mixing, pressed into tablets and dried at low temperature, The temperature is controlled at 10° C., and the medicine for treating fatty liver is obtained after packaging.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses medicine for treating fatty liver. The medicine for treating fatty liver is prepared from the major raw materials in parts by weight: 8 to 20 parts of L-glutamine, 0.2 to 0.6 part of D-tryptophan, 4 to 8 parts of patchouli alcohol, 0.2 to 0.7 part of geraniin, 10 to 20 parts of glucurolactone, 3 to 7 parts of corilagin, 0.9 to 1.5 parts of quercetin, 0.2 to 0.5 parts of sodium danshensu, 4 to 6 parts of ethyl p-methoxy cinnamate and 1 to 3 parts of silymarin. The medicine has the advantages that the symptoms and the physical symptoms of a fatty liver patient are obviously relieved; the blood lipid metabolism action can be obviously regulated; the characteristics of good curative effect, short treatment course, low cost, basically no toxic and side effects and the like are realized; popularization and application values are realized in an aspect of treating the fatty liver.

Description

technical field [0001] The invention relates to the field of medicine preparation, in particular to a medicine for treating fatty liver. Background technique [0002] Under normal circumstances, fat accounts for 3% to 5% of the total weight of the liver. Fatty liver occurs when the fat content exceeds 1 / 10 of the liver weight or more than half of the liver cells become fatty. Its pathogenesis has not been fully clarified so far. It is generally believed that the imbalance between the synthesis of triacylglycerol and the secretion of very low-density lipoprotein in liver cells is the main cause of fatty liver, and this imbalance is due to the increase of fat synthesis or oxidation in liver cells. caused by the reduction. With the change of living habits and diet structure, the enhancement of health care awareness, and the improvement of detection methods, the incidence and detection rate of fatty liver have gradually increased, and it has become a common hidden danger that ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/7048A61K31/198A61K31/045A61K31/7024A61K31/352A61K31/192A61K31/216A61K31/357A61P1/16A61P3/06
CPCA61K31/7048A61K31/045A61K31/192A61K31/198A61K31/216A61K31/352A61K31/357A61K31/7024A61K2300/00
Inventor 不公告发明人
Owner 郑州莉迪亚医药科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com